Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Lymphomas

Variation in the frequency of Epstein–Barr virus-associated Hodgkin's disease with age

Abstract

A number of studies in developed countries have reported variation in the frequency of Epstein–Barr virus (EBV)-associated Hodgkin's disease (HD) with age. A ‘three disease’ model for HD that incorporates the EBV association, histological subtype of HD and age has recently been proposed. In this model, Hodgkin's disease of childhood and older adults is commonly EBV-associated and of mixed cellularity type, whereas young adult HD is generally not EBV-associated and is usually characterised by nodular sclerosis disease. A case series of HD diagnosed in the West Midlands between 1981 and 1997, inclusive, was used to investigate the applicability of the ‘three disease’ model. In situ hybridisation for the EBV early RNAs (EBERs) was used to determine the presence of EBV in the malignant Hodgkin/Reed–Sternberg cells. In contrast to the ‘three disease’ model, nodular sclerosis was the predominant subtype in each of the age groups within the case series. In addition, overall there was little variation in EBV-positive rates across the age ranges examined. However, when females were analysed separately, older women (45+ years) were significantly more likely to have EBV-positive disease than their younger counterparts (<45 years). in summary our results do not generally support the ‘three disease’ model.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

Cristina López, Birgit Burkhardt, … Reiner Siebert

References

  1. MacMahon B . Epidemiology of Hodgkin's disease Cancer Res 1966 26: 1189–1200

    CAS  PubMed  Google Scholar 

  2. Correa P, O'Conor GT . Epidemiologic patterns of Hodgkin's disease Int J Cancer 1971 8: 192–201

    Article  CAS  PubMed  Google Scholar 

  3. Alexander FE, McKinney PA, Williams J, Ricketts TJ, Cartwright RA . Epidemiological evidence for the ‘two-disease hypothesis’ in Hodgkin's disease Int J Epidemiol 1991 20: 354–361

    Article  CAS  PubMed  Google Scholar 

  4. Gutensohn NM . Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the ‘two-disease hypothesis’ Cancer Treat Rep 1982 66: 689–695

    CAS  PubMed  Google Scholar 

  5. Gutensohn N, Cole P . Epidemiology of Hodgkin's disease Semin Oncol 1980 7: 92–102

    CAS  PubMed  Google Scholar 

  6. Cozen W, Katz J, Mack TM . Risk patterns of Hodgkin's disease in Los Angeles vary by cell type Cancer Epidem Biomar 1992 1: 261–268

    CAS  Google Scholar 

  7. Alexander FE, Daniel CP, Armstrong AA, Clark DA, Onions DE, Cartwright RA, Jarrett RF . Case clustering, Epstein–Barr virus Reed–Sternberg cell status and herpes virus serology in Hodgkin's disease: results of a case control study Eur J Cancer 1995 31A: 1479–1486

    Article  CAS  PubMed  Google Scholar 

  8. Levine PH, Pallesen G, Ebbesen P, Harris N, Evans AS, Mueller N . Evaluation of Epstein–Barr virus antibody patterns and detection of viral markers in the biopsies of patients with Hodgkin's disease Int J Cancer 1994 59: 48–50

    Article  CAS  PubMed  Google Scholar 

  9. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J . Hodgkin's disease and Epstein–Barr virus. Altered antibody pattern before diagnosis New Engl J Med 1989 320: 689–695

    Article  CAS  PubMed  Google Scholar 

  10. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H . Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization Blood 1989 74: 810–816

    CAS  PubMed  Google Scholar 

  11. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J . Epstein–Barr viral DNA in tissues of Hodgkin's disease Am J Pathol 1987 129: 86–91

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Wu TC, Mann RB, Charache P, Hayward SD, Staal S, Lambe BC, Ambinder RF . Detection of EBV gene expression in Reed–Sternberg cells of Hodgkin's disease Int J Cancer 1990 46: 801–804

    Article  CAS  PubMed  Google Scholar 

  13. Grässer FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W, Reynolds G, Niedobitek G, Young LS, Mueller-Lantzsch N . Monoclonal antibodies directed against the Epstein–Barr virus-encoded nuclear antigen 1 (EBNA 1): immunohistologic detection of EBNA 1 in the malignant cells of Hodgkin's disease Blood 1994 84: 3792–3798

    PubMed  Google Scholar 

  14. Murray PG, Young LS, Rowe M, Crocker J . Immunohistochemical demonstration of the Epstein–Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease J Pathol 1992 166: 1–5

    Article  CAS  PubMed  Google Scholar 

  15. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS . Expression of Epstein–Barr virus latent gene products in tumour cells of Hodgkin's disease Lancet 1991 337: 320–322

    Article  CAS  PubMed  Google Scholar 

  16. Niedobitek G, Kremmer E, Herbst H, Whitehead L, Dawson CW, Niedobitek E, Von Ostau C, Rooney N, Grässer FA, Young LS . Immunohistochemical detection of the Epstein–Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis Blood 1997 90: 1664–1672

    CAS  PubMed  Google Scholar 

  17. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS . Epstein–Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells J Exp Med 1993 177: 339–349

    Article  CAS  PubMed  Google Scholar 

  18. Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF . Epstein–Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis Leukemia 1998 12: 1272–1276

    Article  CAS  PubMed  Google Scholar 

  19. Jarrett AF, Armstrong AA, Alexander E . Epidemiology of EBV and Hodgkin's lymphoma Ann Oncol 1996 7: S5–S10

    Article  Google Scholar 

  20. Jarrett RF, Gallagher A, Jones DB, Alexander FE, Krajewski AS, Kelsey A, Adams J, Angus B, Gledhill S, Wright DH, Cartwright RA, Onions DE . Detection of Epstein–Barr virus genomes in Hodgkin's disease: relation to age J Clin Pathol 1991 44: 844–848

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O'Grady J, Hummel M, Preciado MV, Knecht H, Chan JK, Claviez A . Epstein–Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data Int J Cancer 1997 70: 375–382

    Article  CAS  PubMed  Google Scholar 

  22. Armstrong AA, Shield L, Gallagher A, Jarrett RF . Lack of involvement of known oncogenic DNA viruses in Epstein–Barr virus-negative Hodgkin's disease Br J Cancer 1998 77: 1045–1047

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Office of population of censuses and surveys . County Monitor. 1991 Census. West Midlands. CEN 91 CM 43 Office of Population of Censuses and Surveys: London 1992

  24. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H, Pileri SA, Piris NA, Ralfkiaer E, Warnke RA . A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361–1392

    CAS  PubMed  Google Scholar 

  25. Barletta JM, Kingma DW, Ling Y, Charache P, Mann RB, Ambinder RF . Rapid in situ hybridization for the diagnosis of latent Epstein–Barr virus infection Mol Cell Probe 1993 7: 105–109

    Article  CAS  Google Scholar 

  26. Stoler MH, Nichols GE, Symbula M, Weiss LM . Lymphocyte predominance Hodgkin's disease. Evidence for a kappa light chain-restricted monotypic B-cell neoplasm Am J Pathol 1995 146: 812–818

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Linden MD, Fishleder AJ, Katzin WE, Tubbs RR . Absence of B-cell or T-cell clonal expansion in nodular lymphocyte predominant Hodgkin's disease Hum Pathol 1988 19: 591–594

    Article  CAS  PubMed  Google Scholar 

  28. Sloane JP . Histopathology of Hodgkin's disease. In: Selby P, McElwain TJ (eds) Hodgkin's Disease Blackwell Scientific Publications: London 1987 pp 4–30

    Google Scholar 

  29. Ambinder RF, Browning PJ, Lorenzana I, Leventhal BG, Cosenza H, Mann RB, MacMahon EME, Medina R, Cardona V, Grufferman S, Olshan A, Levin A, Petersen EA, Blattner W, Levine PH . Epstein–Barr virus and childhood Hodgkin's disease in Honduras and the United States Blood 1993 81: 462–467

    CAS  PubMed  Google Scholar 

  30. Liu S-M, Chow K-C, Chiu C-F, Tzeng C-H . Expression of Epstein–Barr virus in patients with Hodgkin's disease in Taiwan Cancer 1998 83: 367–371

    Article  CAS  PubMed  Google Scholar 

  31. Herbst H, Thorsten R, Stein H . Phenotypic modulation of Hodgkin and Reed–Sternberg cells by Epstein–Barr virus J Pathol 1996 179: 54–59

    Article  CAS  PubMed  Google Scholar 

  32. Khan G, Norton AJ, Slavin G . Epstein–Barr virus in Hodgkin disease: relation to age and subtype Cancer 1993 71: 3124–3129

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to the West Midlands Cancer Intelligence Unit for help in the collection of data. PGM is supported by a West Midlands NHS Executive LORS award.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flavell, K., Biddulph, J., Constandinou, C. et al. Variation in the frequency of Epstein–Barr virus-associated Hodgkin's disease with age. Leukemia 14, 748–753 (2000). https://doi.org/10.1038/sj.leu.2401724

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401724

Keywords

This article is cited by

Search

Quick links